Stevanato Group

Activities: Pharmaceutical

Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries. Stevanato Group delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle at each of the development, clinical, and commercial stages.
Stevanato Group counts more than 5,600 people in 16 sites in 9 countries.

Trending Articles

  1. ReciBioPharm attains Bill & Melinda Gates Foundation grant to achieve continuous RNA manufacturing The biologics CDMO hopes to bring RNA medicines to more patients globally by providing its xRNA continuous manufacturing technology to lower and middle income countries
  2. Arterex completes acquisition of medical device manufacturer Phoenix The medical device specialist will have access to Phoenix's Modena facility, which has four ISO 8 cleanrooms for sterile assembly and packaging and 37,000 sqft of manufacturing...
  3. C.P.M. Contractpharma GmbH and Co. KG
  4. Broughton welcomes FDA authorisation of ZYN Nicotine Pouches Broughton welcomes the US Food and Drug Administration’s (FDA) decision to authorise ZYN nicotine pouches for sale
  5. Gerresheimer & Bormioli Pharma make their first joint trade show appearance at Pharmapack 2025 The companies will showcase their containment and primary packaging solutions, as well as their digital and drug delivery systems for the pharmaceutical market

Upcoming event

Pharma Packaging and Labelling Forum

5–6 March 2025 | Conference | San Diego, US See all

Related Content

Packaging

Nipro launches D2F Glass Vials powered by Stevanato Group's EZ-fill Technology

Nipro PharmaPackaging, a global leader in glass tubing, glass primary packaging, and medical devices, is proud to announce the launch of its innovative D2F (Direct-to-Fill) glass vials
Manufacturing

SCHOTT, Gerresheimer and Stevanato Group form the 'Alliance for RTU'

The scheme will promote the adoption of ready-to-use (RTU) vials and cartridges for CDMOs in the injectable scene
Manufacturing

Quantoom collaborates with Stevanato to elevate mRNA production

The two companies have entered into a collaboration to promote and democratise access to mRNA production technologies worldwide by launching Quantoom's Nfinity platform
Distribution

DWK enters into distribution agreement with drug containment specialist Stevanato

The collaboration will leverage DWK Life Sciences experience in supplying a global network of laboratories and biopharma customers to broaden the distribution of RTU products
Drug Delivery

Expanding capacity through collaboration

Michael Earl, Director of Pharmaceutical Services at Owen Mumford, and Steven Kaufman, Vice President for Drug Delivery Systems, Stevanato Group, talk to Dr Kevin Robinson about their new partnership
Manufacturing

Industry first experiments break the mould for the VHP decontamination of RTU vials

Markus Heinz, Product Manager, Vial Liquid and Powder at Syntegon, and Fabio Bertacchini, Product Management Director at Stevanato Group, present new possibilities for small batch manufacturing
Distribution

Manufacturing Chemist LIVE 2022 in review (part II)

Taking a front row seat during the two-day pharmaceutical conference in Birmingham, UK, Dr Kevin Robinson reports on what’s new, emerging and exciting in the world of drug delivery and beyond
Subscribe now